Essex Investment Management Co. LLC Takes $1.58 Million Position in Nutex Health Inc. (NASDAQ:NUTX)

Essex Investment Management Co. LLC bought a new position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 72,785 shares of the company's stock, valued at approximately $1,579,000. Essex Investment Management Co. LLC owned 1.46% of Nutex Health at the end of the most recent reporting period.

Separately, One Plus One Wealth Management LLC raised its holdings in Nutex Health by 2,017.5% during the first quarter. One Plus One Wealth Management LLC now owns 5,293,720 shares of the company's stock worth $508,000 after acquiring an additional 5,043,720 shares in the last quarter. Hedge funds and other institutional investors own 5.32% of the company's stock.

Insider Buying and Selling at Nutex Health

In related news, CFO Jon Christian Bates bought 1,350 shares of the company's stock in a transaction that occurred on Thursday, August 22nd. The shares were bought at an average price of $21.46 per share, for a total transaction of $28,971.00. Following the completion of the acquisition, the chief financial officer now owns 2,277 shares of the company's stock, valued at $48,864.42. This trade represents a 100.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 38.52% of the company's stock.

Nutex Health Stock Performance

NUTX stock traded up $0.87 during midday trading on Friday, reaching $19.79. 45,091 shares of the company's stock traded hands, compared to its average volume of 39,549. The firm has a market capitalization of $98.40 million, a PE ratio of -1.87 and a beta of 0.10. Nutex Health Inc. has a 52 week low of $4.16 and a 52 week high of $45.00. The company has a 50-day moving average price of $19.41 and a two-hundred day moving average price of $11.46. The company has a debt-to-equity ratio of 3.04, a quick ratio of 1.55 and a current ratio of 1.59.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.22. Nutex Health had a negative net margin of 13.73% and a negative return on equity of 43.79%. The business had revenue of $76.08 million during the quarter.

Analyst Upgrades and Downgrades

A number of research firms have commented on NUTX. Maxim Group began coverage on Nutex Health in a research note on Wednesday, September 18th. They set a "buy" rating and a $45.00 price objective on the stock. Benchmark boosted their target price on Nutex Health from $30.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, August 21st.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.